Effect of supplemental oxygen in prevention of contrast nefropathy

Effect of supplemental oxygen in prevention of contrast nefropathy in patients referring to angiography center.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014082618936N1

Enrollment

430

Registered

2014-10-10

Start date

2014-09-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast nefropathy. Nephropathy induced by heavy metals

Interventions

Intervention 1: Control group will recieve normal saline 1ml/kg/h startin 12hours before to 12 hours after contrast agent administration. Patients will receive 100-200ml contrast agent. Diuretics will

Prevention

Treatment - Other

Control group will recieve normal saline 1ml/kg/h startin 12hours before to 12 hours after contrast agent administration. Patients will receive 100-200ml contrast agent. Diuretics will be held 24 hour

Intervention group:these patients will recieve nasal oxygen 2-3 litr/min from 10 min befor procedure up to the end of the procedure in addition to normal saline 1ml/kg/h from 12 hours before to 12 ho

Eligibility

Sex/Gender

All

Age

35 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: male or female patients older than 35 years old. Exclusion criteria: cardiogenic shock; CHF; ACS; acute MI; COPD; ESRD under dialysis; O2 SAT < %90; need for emergency CABG.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum creatinin. Timepoint: 48 hours later. Method of measurement: laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Ramezanzade

Tehran University of Medical Sciences

rz.elam58@gmail.com; dr.cardiolog58@yahoo.com+98 21 6658 1568

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026